Position in SCLX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$100,118
-$83,283 QoQ
Shares Held
15,033
0.0% QoQ
Ownership
0.177%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $32,017,413,359 across 17 Drug Manufacturers - General names. SCLX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,827,564 | $8,119,328,534 | |
| 2 | JNJ |
Johnson & Johnson
|
29,319,669 | $7,166,899,886 | |
| 3 | ABBV |
AbbVie Inc.
|
21,211,382 | $4,613,263,466 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,090,023 | $3,258,658,860 | |
| 5 | AMGN |
Amgen Inc
|
6,217,838 | $2,187,746,295 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
13,820,379 | $1,926,146,218 | |
| 7 | PFE |
Pfizer Inc
|
62,026,552 | $1,741,705,574 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
24,758,771 | $1,501,619,457 |
All Filings in SCLX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,118 | 15,033 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $183,401 | 15,033 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $298,287 | 15,157 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||